SCHEMBL22929161

SCHEMBL22929161

Cc1cccc2cc(CN)n(-c3ccccc3)c(=O)c12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 6/20 0.41
PIK3R1 P27986 2/20 0.41
PIK3CG P48736 2/20 0.41
CYP1A2 P05177 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 2/20 0.35
HKDC1 Q2TB90 1/20 0.35
ALDH1A1 P00352 3/20 0.35
RXFP1 Q9HBX9 1/20 0.35
TSHR P16473 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
TP53 P04637 1/20 0.35
LOX P28300 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL935611 0.89 PIK3CD (0.48) PIK3CDPIK3R1PIK3CGCYP1A2SMN1; SMN2
SCHEMBL12943411 0.89 PIK3CD (0.42) PIK3CDPIK3R1PIK3CGCYP1A2SMN1; SMN2
SCHEMBL17807063 0.86 PIK3CD (0.39) PIK3CDPIK3R1PIK3CGCYP1A2SMN1; SMN2
SCHEMBL18708426 0.86 PIK3CD (0.53) PIK3CDPIK3R1PIK3CGCYP1A2LMNA
SCHEMBL14726533 0.83 PIK3CD (0.43) PIK3CDPIK3R1PIK3CG
SCHEMBL16596154 0.81 ALDH1A1 (0.43) PIK3CDPIK3R1PIK3CGCYP1A2SMN1; SMN2
SCHEMBL31594596 0.78 PIK3CD (0.49) PIK3CDPIK3R1PIK3CGCYP1A2
SCHEMBL4411785 0.78 PIK3CD (0.49) PIK3CDPIK3R1PIK3CGCYP1A2
SCHEMBL31594651 0.78 PIK3CD (0.49) PIK3CDPIK3R1PIK3CGCYP1A2
SCHEMBL4413901 0.78 PIK3CD (0.49) PIK3CDPIK3R1PIK3CGCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10906907-B2 Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof ICOS CORPORATION (US) 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10906907-B2 Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof PIK3CD, PIK3CA, PIK3CB PIK3CD 1/4885PIK3R1 17/4885PIK3CG 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.